CASE REPORT. Membranoproliferative associated with type II in a renal transplant patient with hepatitis C. Glomerulonefrite membranoproliferativa em. Disease definition. Dense deposit disease, a histological subtype of MPGN (see this term) is an idiopathic chronic progressive kidney disorder distinguished by. Glomerulonefrite membranoproliferativa. Classificação Até achados estruturais e histopatológico fisiopatologia e.

Author: Voodoozahn Donris
Country: Ghana
Language: English (Spanish)
Genre: Medical
Published (Last): 4 May 2005
Pages: 373
PDF File Size: 14.62 Mb
ePub File Size: 16.94 Mb
ISBN: 560-1-42090-778-7
Downloads: 59191
Price: Free* [*Free Regsitration Required]
Uploader: Salkis

He was treated with methylprednisolone pulses followed by oral prednisolone in association with rituximab. Rheumatology Oxford ;45 7: Einollahi B, Alavian SM.

Int J Nephrol membraonproliferativa doi: This diagnostic was surprising since the patient presented with sustained negative viral load, but there are other reported cases in the literature of HCV-related glomerulonephritis in patients with undetectable HCV-RNA We describe a case of membranoproliferative associated with type II in a renal transplant patient with hepatitis C.

Glomerulonefrite membranoproliferativa by Isabela Alcântara on Prezi

The patient did not receive any previous antiviral therapy. Am J Kidney Dis ;46 4: He was admitted in the hospital for further investigation. Detailed information Professionals Clinical genetics review English Am J Transplant ;5 6: The treatment with Rituximab allowed an improvement in renal function. Hepatitis C virus-associated glomerulonephritis without hepatitis C virus in the blood. The documents contained in this web site are presented for information purposes only.

Antiviral therapy is not routinely membfanoproliferativa in a renal transplant patient because of concerns regarding allograft rejection. The patient was lost for follow-up. Nephrol Dial Transplant ;21 8: Membranoproliferative glomerulonephritis type 2 Prevalence: In our case, the patient presented with membranlproliferativa severe renal disease that demanded a more aggressive approach.


Glomerulonefrite membranoproliferativa

The HCV is an independent risk factor for graft loss and proteinuria after transplantation 4,5, The management is critical and the main purpose is to improve long-term allograft survival. According to KDIGO clinical practice guidelines oftreatment with interferon should be reserved to patients with fibrosing cholestatic hepatitis or life-threatening vasculitis Kidney Int Suppl ; All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

Iran J Kidney Dis ;4 1: Crioglobulinemia; glomerulonefrite membranoproliferativa; hepatite C; rituximab; transplante renal.

Clin Transplant ;20 6: To assess the association between race and type of glomerulonephritis, taking into account age, gender and the presence of hepatosplenic schistosomiasis mansoni. Os golmerulonefrite laboratoriais demonstraram: Fabrizi F, Martin P, V. His baseline serum creatinine SCr was 1. Race was significantly associated with histologic type; the odds of being classified as black or mulatto were approximately 2.

The association between race and histologic type was not influenced membranoproliferativz the potential effects of age, gender and hepatosplenic schistosomiasis. Am J Transplant ;1 2: We report a case of membranoproliferative glomerulonephritis associated with type II in a year-old Caucasian male recipient of a deceased kidney transplant in He had a history of illicit drug abuse cocaine and heroin with methadone replacement therapy since Clin J Am Soc Nephrol ;4 1: For all other comments, please send your remarks via contact us.

Two months after the last dose of rituximab, the SCr improved to 1. Post-transplantation morbidity in renal transplant patients with hepatitis C virus HCV infection may be partially explained by the risk of de novo or recurrent HCV associated glomerulopathieswhich can lead to allograft dysfunction.


The main goal of antiretroviral therapy before transplantation is to achieve sustained viral response, because the risk of hepatic and extra hepatic complications is reduced. Despite the presence of anti-HCV antibodies, the viral load remained undetectable.

Dense deposit disease, a histological subtype of Membranoprooliferativa see this term is an idiopathic chronic progressive kidney disorder distinguished by the presence of intra-membranous dense deposits in addition to immune complex subendothelial deposits in the glomerular capillary walls.

Renal function progressively worsened to a maximum of SCr of 2. Hepatitis C and kidney transplantation. The identification of the mechanisms that determine this racial difference represents an important question for future investigations. Hepatitis C infection and chronic renal diseases. The most common HCV-related nephropathy is membranoproliferative glomerulonephritis MPGNusually in the context of cryoglobulinaemia 6,7.

A year-old Caucasian male with a history of chronic kidney disease associated with HCV-related membranoproliferative MPGNhad a cadaveric renal transplant in membranoproliferatica His baseline serum creatinine after transplantation was 1. Its use is not recommended in patients with renal transplant. To date, there are no studies of this therapy in renal transplant and randomized controlled trials are needed After the last infusion, the patient restarted use of cocaine and was lost for follow-up.